Search Results - Morgan Decarli
- Showing 1 - 1 results of 1
-
1
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study by Benjamin A. Teply, Hao Wang, Brandon Luber, Rana Sullivan, Irina Rifkind, Ashley Bruns, Avery Spitz, Morgan Decarli, Victoria J. Sinibaldi, Caroline F. Pratz, Changxue Lu, John L. Silberstein, Jun Luo, Michael T. Schweizer, Charles G. Drake, Michael A. Carducci, Channing J. Paller, Emmanuel S. Antonarakis, Mario A. Eisenberger, Samuel R. Denmeade
Published 2017Artigo